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Abstract
Formation of the Drosophila larval body wall muscles requires the specification, coordinated cellular behaviors and fusion of two cell types:
Founder Cells (FCs) that control the identity of the individual muscle and Fusion Competent Myoblasts (FCMs) that provide mass. These two cell
types come together to control the final size, shape and attachment of individual muscles. However, the spatial arrangement of these cells over
time, the sequence of fusion events and the contribution of these cellular relationships to the fusion process have not been addressed. We analyzed
the three-dimensional arrangements of FCs and FCMs over the course of myoblast fusion and assayed whether these issues impact the process of
myoblast fusion. We examined the timing of the fusion process by analyzing the fusion profile of individual muscles in wild type and fusion
mutants. We showed that there are two temporal phases of myoblast fusion in wild type embryos. Limited fusion events occur during the first 3 h
of fusion, while the majority of fusion events occur in the remaining 2.5 h. Altogether, our data have led us to propose a new model of myoblast
fusion where the frequency of myoblast fusion events may be influenced by the spatial arrangements of FCs and FCMs.
© 2007 Elsevier Inc. All rights reserved.Keywords: Muscle; Fusion; Drosophila; Founder Cell; Fusion Competent MyoblastIntroduction
Muscles are highly specialized, multinucleate cells formed
by the fusion of mononucleate myoblasts. Multiple studies have
demonstrated the conservation of cellular and molecular events
required for fusion. Myoblasts in both Drosophila and
vertebrates undergo the same cellular behaviors during fusion,
including cell recognition, adhesion and membrane alignment.
This conservation extends to the subcellular events observed by
electron microscopy including the detection of electron dense
plaques at the site of membrane breakdown (Abmayr and
Kocherlakota, 2006; Beckett and Baylies, 2006; Doberstein et
al., 1997; Horsley and Pavlath, 2004). However, myoblast
fusion in Drosophila occurs over a relatively short period of
hours, in contrast to vertebrate systems where fusion takes place
over several days. Consequently, the larval body wall muscles⁎ Corresponding author. Fax: +1 646 422 2355.
E-mail address: m-baylies@ski.mskcc.org (M.K. Baylies).
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doi:10.1016/j.ydbio.2007.06.024of Drosophila have provided a relatively simple system in
which to study muscle development and myoblast fusion
in vivo.
Muscles in the Drosophila embryo arise from two popula-
tions of myoblasts that are specified in the developing somatic
mesoderm. These are Founder Cells (FCs), which are thought to
guide muscle formation, and Fusion Competent Myoblasts
(FCMs) that are thought to play a more passive role (Baylies et
al., 1998; Frasch, 1999). Within the somatic mesoderm of each
hemisegment, FCs are specified at stereotypical positions. Each
FC determines the position of a specific muscle with respect to
the anterior–posterior (A–P) and dorsal–ventral (D–V) axes of
the embryo. The FC then fuses to a stereotypical number of
surrounding FCMs to give each muscle its characteristic size
(Bate, 1990; Bate, 1993).
Several Drosophila mutants have been identified that block
myoblast fusion (Abmayr and Kocherlakota, 2006; Beckett and
Baylies, 2006). One class of fusion mutants appeared to block
all myoblast fusion and includes myoblast city (mbc) (Erickson
et al., 1997; Rushton et al., 1995). A second class of mutants
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fuse (blow) (Doberstein et al., 1997; Schroter et al., 2004),
rolling pebbles (rols, also know as antisocial) (Chen and Olson,
2001; Menon and Chia, 2001; Rau et al., 2001) and kette
(Schroter et al., 2004). Based on these observations, it has been
proposed that there are two steps of myoblast fusion: each FC
fuses 2–3 times to form a precursor cell in the first step of fusion
and then all subsequent fusion events occur in the second step.
Each step requires a specific subset of genes (Rau et al., 2001;
Schroter et al., 2004).
Other studies focused on the subcellular events that occur
between fusing myoblasts using transmission electron micro-
scopy (TEM). This analysis has been incorporated into the
two-step model to suggest that only the second step of fusion
requires those subcellular behaviors (Schroter et al., 2004).
However, there are aspects of this model that need further
investigation. First, this model suggested that two distinct
subcellular mechanisms responsible for myoblast fusion have
arisen during evolution, but how this would have occurred is
unclear. Second, a detailed and quantitative analysis, includ-
ing TEM, has not been performed for all fusion mutants.
The description of myoblast cell behaviors and arrangements
during fusion is largely limited to a seminal paper by Michael
Bate in 1990. These studies showed that myoblast fusion begins
at the onset of germband retraction at stage 12 (7.5 h After Egg
Laying [AEL]) and continues until stage 15 (13 h AEL). As
fusion begins, the mesoderm consists of a loosely organized
sheet of cells in direct contact with the ectoderm and central
nervous system (CNS), with a variable number of cells below.
The initial 2–3 nuclei-containing myotubes are found in the
outer layer of the mesoderm in direct contact with the ectoderm
or CNS (Bate, 1990). However, the precise three-dimensional
arrangements of FCs and FCMs, and how these spatial
relationships change during the period of myoblast fusion,
were not investigated. In addition, the timing of fusion in
individual muscles has not been analyzed. The absence of this
essential knowledge is currently hampering our understanding
of both the fusion process and the contribution of individual
genes to this process.
Using imaging techniques and markers that label both
FCs/myotubes and FCMs, we have developed a new model of
myoblast fusion. We have determined the spatial arrangements
of these cell types and uncovered new cell behaviors
throughout the course of myoblast fusion. By combining
these approaches with FC identity markers, we have con-
structed the first map showing the arrangement of FCs as
fusion begins. Using this information, we have analyzed the
timing of fusion events in individual muscles (the “fusion
profile”). These data revealed that there are two temporal
phases of fusion. We have then examined the fusion profile of
individual muscles in fusion mutants. Based on these data, we
propose a new model of myoblast fusion where the frequency
of fusion events is influenced by FC and FCM spatial
arrangements. This work highlights the importance of under-
standing the spatial arrangements of cells that contribute to
organ formation in Drosophila and, by extension, in vertebrate
systems.Materials and methods
Drosophila genetics
All stocks were grown on standard cornmeal medium at 25 °C. Fly stocks
used were: rp298-lacZ (Nose et al., 1998), twi-CD2 (Borkowski et al., 1995),
kette J4–48 (Hummel et al., 2000), ants/rolsT627 (Chen and Olson, 2001),
lonerT1032 (Chen et al., 2003), mbcC1 (Rushton et al., 1995), blow1 (Doberstein
et al., 1997) and Rac1J11 Rac2Δ mtlΔ (Hakeda-Suzuki et al., 2002). Mutants
were balanced using CyO P[w+ wgen11 lacZ] or TM3 Sb1 Dfd-lacZ and
homozygotes were identified by absence of β-galactosidase staining.
Immunohistochemistry
Embryos were fixed in 4% paraformaldehyde/heptane for all immunohis-
tochemistry. Antibodies were preabsorbed (PA) 1:10 against fixed wild type
embryos where stated. Antibody dilutions used were: mouse anti-β-gal (1:2000;
Promega), rabbit anti-β-gal (1:5000; Cappel), chicken anti-β-gal (1:1000;
Abcam), rabbit anti-Lmd (1:250; PA; a gift from H. Nguyen), mouse anti-GFP
(1:400; PA; Clonetech), mouse anti-Cyclin B (1:20; Developmental Studies
Hybridoma Bank), rabbit anti-Eve (1:3000; PA; a gift from M. Frasch), guinea
pig anti-Kr (1:500; PA; a gift from J. Reinitz), rabbit anti-Collier (1:150; PA; a
gift of A. Vincent; used in combination with TSA-FITC system from
PerkinElmer), guinea pig anti-Runt (1:2000; PA; a gift of J. Reinitz) and rabbit
anti-Slouch (1:200; PA) (Cox and Baylies, 2005). Alexa488, Alexa555 and
Alexa647 conjugated secondary antibodies were used (1:400; Molecular
Probes). Alexa546 and Alexa647 conjugated phalloidin was used to visualize
F-actin (1:100; Molecular Probes). Embryos were mounted in ProLong Gold
antifade reagent (Molecular Probes).
Confocal imaging and 3D rendering
Fluorescent images were acquired on a Zeiss LSM 510 confocal
scanning system mounted on an Axiovert 100M microscope with a 63× 1.2NA
C-Apochromat water objective. For confocal microscopy, all pinholes were
set to capture an optical slice of 1.0 μm with optical sections captured
every 0.7–0.8 μm. 488 nm, 543 nm, and 633 nm lasers were used to excite the
fluorochromes. All fluorescent images were exported from Zeiss LSM software
v.3.2. Volocity software was used for 3D rendering of single mesodermal
hemisegments. Images were processed using Adobe Photoshop 7.0 and movies
were created from image sequences using Apple Quicktime.
Staging embryos and nuclei counting
For precise staging all embryos were counterstained using Alexa 546
conjugated phalloidin. In addition to embryonic morphology, the tracheal
system was used as an internal control for staging (Manning and Krasnow,
1993). Nuclei were counted using 40× magnification on a Zeiss Axiophot
microscope using standard fluorescence settings. For each muscle/mutant
condition analyzed, 50 hemisegments (abdominal hemisegments 2–4) at stages
12–15 were counted (17 embryos total). Graphing of data and statistical analysis
were performed with Microsoft Excel.Results
Spatial arrangements of FCs and FCMs during myoblast
fusion
We used recent advances in imaging techniques and markers
for different mesodermal cell types to examine the process of
myoblast fusion and understand the three-dimensional arrange-
ments of FCs and FCMs over the course of this process. We
examined embryos expressing the rp298-lacZ transgene, which
labels the nuclei of all muscle progenitors, FCs and myotubes
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Lameduck (Lmd) that labels the nuclei and cytoplasm of all
FCMs (Duan et al., 2001). To mark out individual cells (rather
than nuclei), we used phalloidin to label the F-actin at the cell
cortex or twi-CD2 expressing embryos to label mesodermal cell
membranes (Borkowski et al., 1995). In this way, all relevant
cells are clearly identified. Using confocal microscopy, we
imaged z-stacks through the somatic mesoderm during stages
12–15 (7.5–13 h AEL). During this period, FC specification isFig. 1. FC and FCM arrangements during myoblast fusion. Single optical slices of rp
and 14 (I–L) embryos labeled with anti-β-gal to label FC/myotube nuclei (green), a
label mesodermal cell membranes (green) are shown. Panels on the left (A, E, I, M)
close-ups of FCMs in panels B, F and J, respectively. Dorsal is up and anterior i
arrows, A, B, F, H, K) were used for accurate staging of embryos (Manning and
extend along the D–V axis during these stages due to germband retraction and dor
present in more external panels (A, E, I, M, N), but not more internal where the major
tightly packed together at stages 12 and 13 (white arrowheads, B–D, F–H, M–P). (I–L
become migratory (white arrowheads, J–L). FCMs in similar locations contact dif
arrows, A, B, F, J). Fusion events can be visualized by colocalization of rp298
containing two nuclei can be observed in external cell layers at late stage 13. No F
beneath the somatic mesoderm at stage 12 and expresses high levels of F-actin (completed, myoblast fusion occurs and the muscles seek out
their attachment sites in the epidermis (Bate, 1990; Bate,
1993). As shown in Fig. 1, the arrangement of somatic
mesodermal cells changes dramatically over this period due to
germband retraction and dorsal closure. Mesodermal hemi-
segments lengthened along the dorsal–ventral (D–V) axis and
narrowed along the anterior–posterior (A–P) axis (compare
Figs. 1A–C to I–K). The depth of the mesodermal
hemisegment changed over this time as well. At stage 12,298-lacZ (A–L) or rp298-lacZ; twi-CD2 (M–P) stage 12 (A–D), 13 (E, F, M–P)
nti-Lmd to label FCMs (blue), phalloidin to label F-actin (red) and anti-CD2 to
are more external than those on the right (C, G, K, P). Panels D, H and L show
s left and scale bars are 20 μm in all panels. The developing trachea (yellow
Krasnow, 1993). Mesodermal hemisegments narrow along the A–P axis and
sal closure (compare panels A–C with panels I–K). FCs/myotubes (green) are
ity of FCMs (blue) are located (B, C, F, G, J, K, O, P). (A–H) FCs and FCMs are
) However, during stage 14 the FCMs separate from one another and round up to
ferent cell types such as other FCMs, FCs/myotubes and epithelial cells (blue
-lacZ and Lmd (white arrow, E) from stage 13 onwards. (M–P) Myotubes
CMs are observed in these cell layers at this stage. The visceral mesoderm is
yellow arrowheads, C).
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(3–4 cell diameters), but by stage 14 this had narrowed to
10–15 μm (2–3 cell diameters). Using this approach, we found
that, in general, FCs/myotubes were in the most external cell
layers in contact with the epidermis and CNS, while FCMs
were more internal (Fig. 1).
We next created three-dimensional renderings of single
mesodermal hemisegments from stages 12–14 (Figs. 2A–C,
Supplementary Movies 1–3). This allowed us to visualize the
spatial arrangements of FCs and FCMs in three dimensions
during myoblast fusion. We observed that the somatic
mesoderm contains multiple layers at stage 12 with the mostFig. 2. Three-dimensional analysis of FC and FCM arrangements demonstrates that FC
rp298-lacZ embryos were stained with antibodies against β-gal to label FC/myotube
(red). (A–C) Three-dimensional renderings of single mesodermal hemisegments at s
unit=14.1 μm) are shown. Each panel shows an external view (left) and a side view
anterior and blue arrows point to external. SM stands for somatic mesoderm and VM
position and expression of high levels of F-actin by phalloidin staining (Fig. 1, data no
FCs (green) are concurrently the most external and internal cells (yellow arrows, A), w
visceral FCs. (B) At stage 13, the internal FCs and FCMs have moved externally to u
top of the FCMs (blue) at this stage and the cells are tightly packed together. (C) By s
fusion. The FCMs (blue) have separated from one another. (D–I) Single confocal sec
13. At stage 12 (D–F), a small number of progenitor cells are still dividing to form
lateral (white arrows, D–F) and ventral (data not shown) positions. By stage 13 no
FCMs are still dividing (white arrows, G–I). Proliferating non-mesodermal cells areventral somatic FCMs contacting the dorsal visceral FCs
(marked by the expression of high levels of structural proteins
such as F-actin, data not shown). The somatic FCs were located
around the outside of the FCMs and therefore were concurrently
the most external and internal cells in the somatic mesoderm at
this stage (Fig. 2A, Supplementary Movie 1). This arrangement
of FCs and FCMs had not previously been described. As
germband retraction proceeds the mesodermal hemisegment
lengthens along the D–V axis and the internal ventral FCs and
FCMs move to directly underlay the epidermis. From these
fixed samples, it appeared that the cells maintain their positions
relative to one another. However, we cannot exclude theMs are not a uniform cell population. Stage 12 (A, D–F), 13 (B, G–I) and 14 (C)
nuclei (green), Lmd to label FCMs (blue) and Cyclin B to label dividing cells
tage 12 (A, 1 grid unit=5.7 μm), 13 (B, 1 grid unit=10.9 μm) and 14 (C, 1 grid
rotated 90° clockwise (right). Red arrows point to dorsal, green arrows point to
stands for visceral mesoderm. The visceral mesoderm was identified based on
t shown). (A) At stage 12, the somatic mesoderm contains multiple layers and the
ith the FCMs (blue) in between. The most ventral and interior FCMs contact the
nderlay the overlaying epidermis (not labeled). The FCs (green) appear to rest on
tage 14, the number of rp298-lacZ expressing nuclei (green) has increased due to
tions showing that a subset of FCMs undergo cell division during stages 12 and
FCs (yellow arrows, D–F). In addition a subset of FCMs are dividing in dorsal,
rp298-lacZ expressing cells are undergoing cell division, but a small number of
located in close proximity to dividing FCMs (blue arrows, F, I).
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process. From stage 13 onwards, the FCs and developing
myotubes were found externally with varying layers of FCMs
internally depending on their position along the D–V axis
(Figs. 2B, C, Supplementary Movies 2 and 3).
FCMs are not a uniform cell population
Our spatial analysis of FC and FCM arrangements indicated
that FCMs that arise in similar locations touched different cell
types. For example, while some FCMs only touched other
FCMs, some touched FCs or epithelial tissues such as the
epidermis and trachea (Fig. 1). Our data also showed that during
the initial stages of myoblast fusion (stages 12–13), the FCs and
FCMs were tightly packed together (Figs. 1A–H). The tight cell
contacts persisted until stage 14 when the internal FCMs
separated from one another and rounded up, acquiring what
appears to be a migratory morphology (Figs. 1I–L). During
stage 13, bi-nucleate myotubes were observed in external cell
layers and FCMs in those layers were no longer detected.
Internal FCMs appeared to be still present in their originalFig. 3. Three-dimensional analysis of FC arrangements shows organization into
stained with an antibody against β-gal to label FC/myotube nuclei (green). (A–C
12 (A, 1 grid unit=5.7 μm), 13 (B, 1 grid unit=10.9 μm) and 14 (C, 1 grid unit=14.1
90° clockwise (right). Red arrows point to dorsal, green arrows point to anterior and b
visceral mesoderm. The visceral mesoderm was identified based on position and exp
these stages, FCs are organized into four groups in the dorsal (red), dorsal–lateral (ye
most ventral FCs are located internally. After germband retraction, these cells move e
arrows). These data gathered at each stage have been confirmed with specific FC ide
counted, based on the position and known sibling relationships of the FCs. This map w
these cells. A map labeling the identity of each muscle is shown in Supplementaryposition (Figs. 1M–P); however, limited cell movements cannot
be ruled out by this analysis. These data indicated that the
external FCMs are responsible for initial fusion events. The
internal FCMs, which do not directly contact FCs, presumably
undergo cell migration and fuse later.
In addition, in contrast to the increase in rp298-expressing
nuclei that we observed due to fusion (Figs. 1–3), we did
not observe the concomitant reduction in the number of
FCMs that we expected at stage 14. While we hypothesized
that this could be partly explained by the alterations in cell
arrangements and interactions during this time, we tested
whether the FCMs divided after their initial specification.
Although it has been assumed that FCMs are all post-mitotic,
analysis of markers for dividing cells, Cyclin B (G1-S phase,
Figs. 2D–I) and phospho-Histone H3 (mitosis; Supplemen-
tary Fig. 1), revealed that a subset of FCMs undergo cell
division during stages 12–13. FCM division is most frequent
at early-mid stage 12 (Figs. 2D–F, 21% FCMs express Cyclin B
in a given optical section, n=278 FCMs) and decreases during
late stage 12 to stage 13 (Figs. 2G–I, 6% FCMs express Cyclin B
in a given optical section, n=449 FCMs). No FCM divisionsfour groups. Stage 12 (A), 13 (B) and 14 (C) rp298-lacZ embryos were
) Three-dimensional renderings of single mesodermal hemisegments at stage
μm) are shown. Each panel shows an external view (left) and a side view rotated
lue arrows point to external. SM stands for somatic mesoderm and VM stands for
ression of high levels of F-actin by phalloidin staining (data not shown). During
llow), lateral (green) and ventral (blue) somatic mesoderm. At stage 12 (A), the
xternally (B–C). Visceral FCs can be clearly seen in the absence of FCMs (put in
ntity markers. (D) A map of FC arrangements, at stage 13 when 30 FCs can be
as made by drawing over a flattened version of panel B to mark the positions of
Fig. 1.
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FCMs appeared in clusters in dorsal, lateral and ventral positions
and occurred both externally and internally. They oftenFig. 4. Analysis of FC identity markers outlines a three-dimensional map of FCs at st
(green, A–E), Collier (red, A), Eve (red, B), Kr (red, C), Runt (red, D) and Slouch (re
panel show an external view. Dorsal is up in all panels and anterior is to the left. Each
Green arrows mark non-mesodermal expression of FC identity genes in the CNS or PN
Fusion of the DA3 muscle has already begun at this stage (yellow arrows, A). (B) Ev
the FCs for the DA1, DO1, LL1, LT2, LT4, VA2, VO2, VO5 and VL3muscles. Fusion
expressed in the FCs for the DO2, VO3 and VO4 muscles. Fusion of the DO2 muscle
the DT1, DO3, LO1, VT1 and VA1–3 muscles at this stage. Fusion has begun in the
also labeled (red arrow, E). (F) Map showing the identity and location of all FCs at sta
groupings of the FCs are shown. FCs labeled in black are those confirmed using F
position. A map showing the position and identity of all muscles in the final musclecontacted proliferating non-mesodermal cells (Figs. 2D–I).
In addition, we observed division of rp298-expressing cells
during stage 12 (Figs. 2D–F). This corresponds to the finalage 13. Stage 13 rp298-lacZ embryos were stained with antibodies against β-gal
d, E). Three-dimensional renderings of single mesodermal hemisegments in each
grid unit represents 10.6 μm (A, D), 11.2 μm (B), 11.3 μm (C) and 10.3 μm (E).
S. (A) Collier is expressed in the FCs for the DA3, DT1, DO4 and DO5muscles.
e is expressed in the FC for the DA1 muscle and two PCs. (C) Kr is expressed in
has begun in all Kr-positive muscles at this stage (yellow arrows, C). (D) Runt is
has begun at this stage (yellow arrow, D). (E) Slouch is expressed in the FCs for
DT1 muscle at this stage (yellow arrow, E). The Slouch expressing ventral AP is
ge 13. The dorsal (red), dorsal–lateral (yellow), lateral (green) and ventral (blue)
C identity markers, while those labeled in grey show those identified based on
pattern is shown in Supplementary Fig. 1.
Fig. 5. Wild type fusion profiles of individual muscles. Wild type stage 12–15
embryos were stained with antibodies against Eve (DA1), Runt (DO2) or Slouch
(DT1, VT1 and VA2) in combination with phalloidin to assist accurate staging.
The number of nuclei for each muscle and stage was counted in 50
hemisegments (A2–4). (A) Bar graph showing the mean number of nuclei for
each muscle at each stage. Error bars show one standard deviation from the
mean. For each muscle, the majority of fusion occurs in stages 14–15. The
stage 12 value for the DT1 muscle was not determined due to an inability to
detect Slouch expression. (B) Histogram showing the percentage of fusion
events that occur during each stage for each muscle during the course of
fusion (7.5–13 h AEL). The mean number of nuclei observed for each muscle
at stage 15 is 100% and a single nucleus is 0%. The numbers used to plot this
graph are shown in Supplementary Table 1. 9–27% of fusion occurs during
stages 12–13 (7.5–10.5 h AEL), while the remaining 73–91% of fusion occurs
during stages 14–15 (10.5–13 h AEL).
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Bate, 1993).
A three-dimensional map of FCs
An understanding of the fusion process requires knowl-
edge of both the identity and the spatial arrangement of FCs
in relation to each other and to the FCMs in the somatic
mesoderm. As shown in Figs. 1 and 2, the positions of FCs
changed during germband retraction as the internal ventral
FCs moved to underlay the epidermis. However, throughout
this process, the FCs were located in four groups that appear
to be maintained throughout stages 12–14. These groups are
shown in Fig. 3. This was most apparent at stage 13, when
approximately 30 rp298-lacZ positive FCs can be counted.
Due to the lag time of β-galactosidase expression, this pattern
reflects an earlier stage of development (stage 12) (Fig. 3B).
There were consistently 4 FCs in the dorsal group, 6 FCs in
the dorsal-lateral group, 6 FCs in the lateral group and
14 FCs in the ventral group, some external and some internal
(Figs. 3A–C). While this grouping was reproducible, the
exact positioning of FCs within a group often varied. How-
ever, the relative position of FCs to one another within a
group formed a characteristic pattern. For example, in the
dorsal group, there was always a most dorsal and a most
ventral FC with two FCs between, one more anterior to the
other (Fig. 3B).
Based on the final position of the muscles, we predicted the
identity of the FCs within each group (Fig. 3D, Supplementary
Fig. 2). We proposed that the dorsal group contains the DO1,
DO2, DA1 and DA2 muscles. The dorsal–lateral group
contains the DO3–5, DA3, DT1 and LL1 muscles. The lateral
group contains the LT1–4, LO1 and SBM muscles and the
ventral group contains the VT1, VA1–3, VL1–4 and VO1–6
muscles. Although the sibling relationships of all FCs are not
currently known, the published data supported our grouping of
the FCs (Supplementary Fig. 3) (Bourgouin et al., 1992;
Carmena et al., 1995, 2002; Crozatier and Vincent, 1999;
Dohrmann et al., 1990; Halfon et al., 2000; Jagla et al., 1998;
Knirr et al., 1999; Nose et al., 1998; Ruiz-Gomez et al., 1997).
To confirm the identity of the FCs in each group and create a
spatial map of FCs, we combined our three-dimensional
imaging approach with FC identity markers (Fig. 4). For this
analysis we used FC identity markers that are expressed during
stage 13 and that, together, label the majority of FCs. These are
Collier, Even-skipped (Eve), Krüppel (Kr), Runt and Slouch
(Carmena et al., 1995, 2002; Crozatier and Vincent, 1999;
Dohrmann et al., 1990; Halfon et al., 2000; Ruiz-Gomez et al.,
1997). Fig. 4F shows the spatial map of FCs. FCs that have been
confirmed using FC identity markers are outlined and labeled in
black, while the others that have been identified based solely on
position are labeled in grey. Double-labeling experiments with
the identity markers verify these assignments (Crozatier and
Vincent, 1999; Carmena et al., 2002; Halfon et al., 2000; Ruiz-
Gomez et al., 1997; Knirr et al., 1999; data not shown). These
data allowed us to account for all rp298-lacZ-expressing FCs
based on their position.The fusion profile of individual muscles
To examine the impact these behaviors could have on fusion,
we next determined the timing of fusion in individual muscles
over the course of the fusion process. To perform a detailed
analysis of the fusion profile of individual muscles, we used FC
identity markers to label individual FC/myotube nuclei. All
embryos were additionally stained using phalloidin to assist in
precise and consistent staging. The complete fusion profile of a
subset of muscles (two dorsal DA1, DO2; one dorsal-lateral
DT1 and two ventral VT1, VA2) was determined.
We began our analysis with the Eve-expressing DA1 muscle
(Halfon et al., 2000; Carmena et al., 2002), as this marker and
Table 1
Wild type fusion profiles of individual muscles
Muscle Stage 12 Stage 13 Stage 14 Stage 15
DA1 1.10±0.30 (1–2) 1.90±0.89 (1–4) 5.02±1.85 (2–9) 9.02±1.65 (6–16)
DO2 1.04±0.20 (1–2) 2.60±1.01 (1–5) 5.42±2.00 (3–9) 10.76±1.82 (8–17)
DT1 n.d. a 1.68±0.68 (1–3) 4.20±1.01 (2–6) 5.74±0.83 (4–8)
VT1 1.00±0.00 (1) 1.44±0.54 (1–3) 2.16±0.65 (1–4) 2.62±0.64 (2–4)
VA2 1.00±0.00 (1) 1.70±0.65 (1–4) 5.98±1.51 (4–8) 8.92±1.54 (6–13)
For each stage and muscle, the average number of nuclei±standard deviation is shown (n=50). The range of nuclei numbers observed is shown in brackets.
a Not determined due to the inability to detect Slouch expression in the DT1 FC at this stage.
120 K. Beckett, M.K. Baylies / Developmental Biology 309 (2007) 113–125muscle have been used as an assay for the number of fusion
events in previous studies (Menon et al., 2005; Schroter et al.,
2004). We counted the number of Eve-expressing FC/
myotube nuclei from stage 12 to 15 in 50 abdominal hemi-
segments (A2–4) for each stage. We focused on a specific set
of hemisegments to control for differences in the number of
fusion events occurring along the A–P axis (K.B. and M.K.
B., unpublished observations) (Bate, 1990). Fusion of the
DA1 FC began at stage 12 and by stage 15 an average ofFig. 6. Fusion profile of the DA1 and DO2 muscles for wild type and fusion mutant em
mbc, kette, rac and rols mutant embryos were stained with antibodies against Eve (D
number of nuclei for each muscle and stage was counted in 50 hemisegments (A2–4)
(C) muscles at each stage in each genotype. Error bars show one standard deviation fr
first class showed almost no fusion and included blow, loner and mbc. The second c
fusion mutants showed fusion at all stages. (B, D) Histograms showing the percentag
of fusion (7.5–13 h AEL). The mean number of nuclei observed for each mutant at sta
are shown in Supplementary Tables 2 and 3. Fusion is observed at all stages of fusi9.02±1.65 nuclei were observed per muscle (n=50 muscles;
Fig. 5A, Table 1, Supplementary Fig. 4A). We found that the
relative proportion of fusion events that occurred at each stage
were distinctly different. During the first half of myoblast
fusion (stages 12–13, 7.5–10.5 h AEL), only 11% of fusion
occurred, while the remaining 89% of fusion occurred in the
second half (stages 14–15, 10.5–13 h AEL) (Fig. 5B,
Supplementary Table 1). This indicated that there may be two
temporal phases of fusion.bryos shows two classes of fusion mutants. Stage 12–15 wild type, blow, loner,
A1, A, B) or Runt (DO2, C, D) in combination with phalloidin (see text). The
. (A, C) Bar graphs showing the mean number of nuclei in the DA1 (A) and DO2
om the mean. For each muscle, two classes of fusion mutants were observed. The
lass showed limited fusion and included kette, rac and rols. The second class of
e of fusion events that occur during each stage for each mutant during the course
ge 15 is 100% and a single nucleus is 0%. The numbers used to plot these graphs
on independent of the number of fusion events that occur.
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positive DO2 muscle (Carmena et al., 2002) also began to fuse
at stage 12 and by stage 15 contained an average of 10.76±
1.82 nuclei (n=50 muscles; Fig. 5A, Table 1, Supplementary
Fig. 4B). Again we observed that 16% of fusion occurred during
stages 12–13, while 84% occurred during stages 14–15
(Fig. 5B, Supplementary Table 1). Analysis of the Slouch-
positive DT1, VT1 and VA2 muscles (Carmena et al., 1995;
Dohrmann et al., 1990; Knirr et al., 1999) supported these results
(14%, 27% and 9% of fusion during stages 12–13, respectively)
(Fig. 5, Table 1, Supplementary Figs. 4C–E, Supplementary
Table 1). Taken together, these data clearly demonstrated that
there are two temporal phases of myoblast fusion in all of the
muscles analyzed. For each muscle analyzed, 9–27% of fusion
events occur in the first half of the fusion process, while the
remaining 73–91% occur in the second half (Fig. 5B,
Supplementary Table 1). This result was consistent for both
larger (e.g. DA1, DO2, DT1 and VA2) and smaller (e.g. VT1)
muscles. These data also indicated that the ventral muscles do
not necessarily begin to fuse before the dorsal muscles as
previously proposed (Bate, 1990; Bate, 1993). For example, the
DA1 and DO2muscles begin to fuse during stage 12, prior to the
VA2 and VT1 muscles that begin to fuse during stage 13.
The fusion profile of fusion mutants
As stated in the Introduction, a two-step model of myoblast
fusion has been proposed based on the analysis of mutants that
block the process at different stages. While the first class of
mutants (e.g. mbc) have been reported to block all fusion
(Erickson et al., 1997; Rushton et al., 1995), the second class of
mutants (e.g. blow, kette, rols) appear to block fusion after the
formation of a 2–3 nuclei precursor cell (Menon and Chia,
2001; Rau et al., 2001; Schroter et al., 2004). However, a
precise analysis of the degree of fusion block in many cases has
not been performed. Our data indicated that there are two
temporal phases of fusion (Fig. 5B, Supplementary Table 1). To
test if the first phase of fusion corresponded to the first step of
fusion in the two-step model, we analyzed the fusion profile of
individual muscles in fusion mutants. If the two phases of fusion
that we described corresponded to the two-step model, we
would expect that in fusion mutants in which 2–3 fusion events
occur, fusion would proceed normally until the end of stage 13
and then stop.Table 2
Fusion profile of the DA1 muscle for wild type and fusion mutant embryos
Genotype Stage 12 Stage 13 S
Wild type 1.10±0.30 (1–2) 1.90±0.89 (1–4) 5
blow 1.14±0.64 (0–3) 1.14±0.53 (0–3) 1
kette 1.16±0.71 (0–3) 1.18±0.52 (0–2) 1
loner 1.06±0.51 (0–3) 1.12±0.56 (0–2) 1
mbc 1.04±0.40 (0–2) 1.08±0.34 (0–2) 0
rac 1.36±0.56 (1–3) 1.42±0.73 (0–3) 2
rols 1.18±0.44 (0–2) 1.44±0.76 (0–4) 1
For each stage and genotype, the average number of nuclei±standard deviation is s
a % of hemisegments lacking any fusion at stage 15 (n=50).We again began by analyzing the fusion profile of the
Eve-expressing DA1 muscle in fusion mutants (Figs. 6A, B,
Table 2, Supplementary Table 2). We indeed observed two
classes of fusion mutants. The first class of mutants showed
almost no fusion events and included blow (1.28±0.54 nuclei at
stage 15, n=50 muscles), loner (1.40±0.73 nuclei at stage 15,
n=50) and mbc (1.00±0.29 nuclei at stage 15, n=50). The
second class of mutants showed 2–4 fusion events at stage
15 and included kette (2.72±1.50 nuclei at stage 15,
n=50 muscles), rac (3.38±1.92 nuclei at stage 15, n=50)
and rols (3.36±nuclei at stage 15, n=50) (Fig. 6A, Table 2). In
contrast to previously published results (Schroter et al., 2004),
blow mutant embryos, which had been described as showing
2–3 fusion events per muscle, showed almost no fusion in our
hands. We propose that this discrepancy was due to the
incomplete penetrance of the blow mutant phenotype. At stage
15, 70% of hemisegments showed no fusion (Table 2) and only
26% of hemisegments showed 1–2 fusion events (n=50).
Because the average number of Eve-expressing nuclei per
hemisegment in blow mutant embryos was 1.28 and hence
comparable to that observed for mbc mutant embryos (Table 2),
we classified blow mutants in the first class of fusion mutants.
Likewise, we classified loner in the first class of fusion mutants,
as we found 1.40 Eve-expressing nuclei per hemisegment in
loner mutant embryos at stage 15 (Fig. 6A and Table 2).
Previous work (Chen et al., 2003) had not precisely identified
the extent of myoblast fusion defect in loner mutant embryos,
yet it had been classified as blocking the first step of fusion
(Schroter et al., 2004). Therefore the first class of fusion
mutants included blow, loner and mbc, while the second class
of fusion mutants included kette, rac, and rols.
Our analysis showed that in mutants that showed limited
fusion, those fusion events occurred over the entire period of
muscle fusion. A size of 2–4 nuclei per myotube was only
achieved by stage 15 in these mutants, in contrast to stages
13–14 in wild type embryos (Figs. 6A, B, Table 2, Sup-
plementary Table 2). This contradicted the prediction of the
two-step model, namely, that fusion should proceed normally in
these mutants, forming a 2–3 nuclei precursor cell, then stop.
Also, no fusion was observed in 14%, 8% and 2% of
hemisegments in kette, rac and rols mutant embryos, respec-
tively (n=50, Table 2). This strongly suggested that these genes
are required for fusion at all stages of the process. In addition,
the rare fusion events observed in blow and loner mutanttage 14 Stage 15 % lacking fusion a
.02±1.85 (2–9) 9.02±1.65 (6–16) 0
.38±0.67 (1–4) 1.28±0.54 (0–3) 70
.58±0.95 (0–5) 2.72±1.50 (0–6) 14
.14±0.53 (0–3) 1.40±0.73 (0–3) 68
.88±0.44 (0–2) 1.00±0.29 (0–2) 92
.36±1.21 (0–6) 3.38±1.92 (0–8) 8
.82±0.96 (0–4) 3.36±1.22 (0–6) 2
hown (n=50). The range of nuclei numbers observed is shown in brackets.
Fig. 7. Model figure showing two temporal phases of myoblast fusion. During
stages 12–13 (7.5–10.5 h AEL) FCs (red and green) are located externally to the
FCMs (blue) and all cells are tightly packed together. There is limited fusion
during this time. During stages 14–15 (10.5–13 h AEL), the FCMs (blue)
separate from one another, migrate externally and fuse to growing myotubes (red
and green). The majority of fusion events occur during this time. We propose
that these two temporal phases are due to differences in the frequency of
individual fusion events and that expression of limiting factors during the first
phase, and the initiation of FCMmigration at the beginning of the second phase,
are responsible for the transition between the two phases. This model combined
with detailed analysis of fusion mutants predicts that subcellular behaviors such
as prefusion complex and plaque formation occur at all stages of the fusion
process.
Table 3
Fusion profile of the DO2 muscle for wild type and fusion mutant embryos
Genotype Stage 12 Stage 13 Stage 14 Stage 15 % lacking fusion a
Wild type 1.04±0.20 (1–2) 2.60±1.01 (1–5) 5.42±2.00 (3–9) 10.76±1.82 (8–17) 0
blow 0.94±0.24 (0–1) 1.04±0.28 (0–2) 1.16±0.47 (0–3) 1.24±0.74 (0–3) 64
kette 1.04±0.20 (1–2) 1.18±0.52 (0–3) 1.80±0.88 (0–4) 1.84±0.98 (0–4) 32
loner 1.02±0.25 (0–2) 1.10±0.30 (1–2) 1.12±0.33 (1–2) 1.06±0.42 (0–2) 82
mbc 0.98±0.14 (0–1) 1.02±0.14 (1–2) 1.00±0.35 (0–2) 1.04±0.40 (0–3) 90
rac 1.04±0.28 (0–2) 1.56±0.64 (0–3) 2.90±1.25 (0–5) 5.50±1.42 (3–9) 0
rols 1.08±0.27 (1–2) 1.14±0.35 (1–2) 1.62±0.60 (0–3) 2.28±0.78 (0–4) 8
For each stage and genotype, the average number of nuclei±standard deviation is shown (n=50). The range of nuclei numbers observed is shown in brackets.
a % of hemisegments lacking any fusion at stage 15 (n=50).
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Supplementary Table 2). To confirm that this was not unique
to the DA1 muscle, we performed the same analysis on the
Runt-expressing DO2 muscle. Analysis of the DO2 muscle
confirmed the results for the DA1 muscle (Figs. 6C, D, Table 3,
Supplementary Table 3). blow, mbc and loner mutant embryos
showed almost no fusion, while kette, rac and rols mutant
embryos showed limited fusion events that occurred over the
entire period of myoblast fusion. These data clearly showed that
the fusion profile of the fusion mutants does not support the
two-step model of fusion. We therefore concluded that the
limited amount of fusion observed in the second class of fusion
mutants was due to inefficient fusion.
Discussion
Organogenesis relies on the coordination of multiple cell
types in space and time. During Drosophila muscle formation,
two distinct myoblast cell types, FCs and FCMs, must organize
their behaviors in space and time to undergo cell–cell fusion
and form individual muscles of a particular size, shape and
orientation. The spatial relationships and behaviors among
these cell types, the molecular underpinnings of these
behaviors over time and the contributions of these to the
fusion process were unknown. We have examined the spatial
arrangements of the FCs and FCMs during myoblast fusion
and morphogenesis. As a result, we constructed the first three-
dimensional map of FCs and FCMs. In addition, we have
identified novel FCM behaviors that occur during fusion,
including cell divisions. The quantitative analysis of fusion
profiles of individual muscles has forced us to reexamine the
existing model of myoblast fusion, the two-step model. This
model formed the framework for the incorporation of new
fusion mutants and has been a paradigm for vertebrate
myogenesis. Our data, however, suggested a new model of
myoblast fusion whereby there are two temporal phases of
fusion with the timing or frequency of individual fusion events
changing dramatically over the course of the fusion process
(Fig. 7). This work highlights the fact that detailed analysis of
cell behaviors and cell spatial arrangements over time are
essential to understand complex processes of organogenesis,
which involve multiple cell types and cell behaviors as
described here for Drosophila muscle formation and myoblast
fusion.Cell arrangements during myoblast fusion
The FCs/myotubes are generally the most external meso-
dermal cells from stage 12 onwards (Figs. 2A–C and 7). While
this has been described and correlates with the fact that the
muscles form directly underneath the epidermis (Bate, 1990;
Doberstein et al., 1997), our work significantly extends these
observations by showing the placement and organization of FCs
with regard to each other and to the contributing FCMs. The use
of phalloidin to label F-actin at the cell cortex allowed
visualization of the spatial relationships between somatic
mesodermal cells. We found that these cells are packed tightly
together during stages 12–13 and appeared to form close cell–
cell contacts (Figs. 1A–H and 7), although the nature of these
contacts remains unknown. However, at the beginning of stage
14, we observed that the cells separated from one another and
the FCMs round up and, we interpret, become migratory (Figs.
1I–L and 7). These data suggested that regulation of cell
adhesion is very important during these stages of muscle
development. The nature of these adhesions, the proteins
responsible and the signal instructing cells to alter cell adhesion
await identification. It is likely that the regulation of these cell
123K. Beckett, M.K. Baylies / Developmental Biology 309 (2007) 113–125contacts and migratory behavior play an essential role in de-
termining the efficiency of the fusion process.
FCMs make an important contribution to muscle
morphogenesis
Previous studies have shown that FCMs have their own
developmental program (Artero et al., 2003; Duan et al., 2001;
Estrada et al., 2006; Furlong et al., 2001; Ruiz-Gomez et al.,
2002) and suggest that FCMs are not a uniform cell population.
The differences in FCM identity are postulated based on the
identification of genes expressed in subsets of FCMs (Artero et
al., 2001; Estrada et al., 2006; Ruiz-Gomez et al., 2002). Our
work has suggested that FCM's position within the hemiseg-
ment has important consequences for their behaviors. FCMs
form cell contacts with FCs, epithelial cells of the epidermis and
trachea, as well as with each other (Fig. 1). It is likely that these
diverse cell contacts contribute to the FCMs differential identity.
For example, our data suggested that FCMs that contact an FC
may be responsible for initial fusion events, while those that do
not, become migratory and contribute to later fusion events
(Figs. 1 and 7). In addition, we observed that a subset of FCMs
at stages 12–13 undergo cell division (Figs. 2D–I). These
dividing cells appear clustered together in a segmentally
repeated pattern indicating that they are responding to a
localized mitogenic signal. It has been shown that both EGF
and FGF are expressed in these regions at these times and
therefore we propose these signaling proteins as possible
candidates (Rutledge et al., 1992; Sutherland et al., 1996). We
are now in a position to determine whether expression of genes
in subsets of FCMs corresponds with the distinct cellular
behaviors described above. These observations will give us a
foothold to test the requirement of these behaviors for myoblast
fusion and muscle morphogenesis.
Moving from a two-step to a two-phase model of myoblast
fusion
The two-step model of myoblast fusion in the Drosophila
embryo states that for each muscle, a 2–3 nuclei precursor cell is
a critical intermediate step during the formation of a multi-
nucleate myotube. This was based on the classification of fusion
mutant into two classes: those showing no fusion and those
showing 1–2 fusion events at the end of muscle development
(Rau et al., 2001; Schroter et al., 2004). Our data examining the
fusion profile of the fusion mutants in detail again showed two
classes of mutants, but with important differences (Fig. 6, Tables
2 and 3, Supplementary Tables 2 and 3). First, we have shown
that in contrast to published data (Schroter et al., 2004), the
amount of fusion observed in blow mutant embryos is directly
comparable to that observed in loner and mbc mutant embryos.
Second, we showed that in fusion mutants where limited fusion
occurs (kette, rols and rac), these fusion events occurred
throughout the period of fusion (stages 12–15). This is
inconsistent with a model where after the formation of a 2–3
nuclei precursor cell, all subsequent fusion events stop in these
mutants. In addition, the observation that in some hemisegmentsno fusion was detected in these mutant embryos (Tables 2 and 3)
indicates that these gene products are required for all fusion
events. Taken together, these data suggested to us that the fusion
process occurs inefficiently in these mutant embryos. We
propose this is due to the remaining gene function in these
mutants due to maternal loading or absence of a true null allele. It
has been documented that Rac and Kette are maternally loaded
(Luo et al., 1994; Schroter et al., 2006) and we observed low
levels of Rols protein in rols mutant embryos (B. Richardson
and M. K. B, unpublished observations). The similarity in the
fusion profiles of kette, rols and rac mutant embryos is
consistent with a similar cause in each.
The current two-step model indicates that the subcellular
events described by EM are unique to the second step of fusion
and therefore that two distinct mechanisms for myoblast fusion
exist. This model is based on the conclusions that mbc is
required for the first step of fusion, while blow and kette are
required for the second step (Schroter et al., 2004). The detailed
level of analysis presented here shows that there is almost no
fusion in blow mutant embryos (Fig. 6, Tables 2 and 3). This
indicates that mutants showing both almost no (mbc and blow)
and limited (kette) fusion show defects at different stages of the
fusion process as analyzed by EM. This suggests that similar
subcellular mechanisms occur for all fusion events. It remains
unclear, however, how proteins that are initially asymmetrically
localized contribute to the first fusion event. Nevertheless this
underscores the difficulty of trying to link the genetic regulation
of cellular and subcellular events in reiterative processes such as
myoblast fusion.
While our data challenge the current two-step model of
fusion and are inconsistent with two distinct mechanisms of
myoblast fusion, it strongly suggested that fusion occurs in two
temporal phases (Fig. 7). 9–27% of fusion occurs in the first 3 h
of fusion, while the remaining 73–91% occurs in the latter 2.5 h
(Fig. 5). This model is consistent with published data (Chen and
Olson, 2001; Chen et al., 2003; Erickson et al., 1997; Kim et al.,
2007; Massarwa et al., 2007; Menon and Chia, 2001; Menon et
al., 2005; Rau et al., 2001; Rushton et al., 1995; Schroter et al.,
2004). No known fusion mutants showed a block at the
transition between these two phases (stage 13 to 14). However,
genetic screens to identify fusion mutants have not yet been
performed to saturation.
How can two temporal phases of fusion occur? We propose
that this is due to either differences in the timing or frequency of
individual fusion events. Live imaging studies indicate that the
timing of individual fusion events does not vary between stages
13 and 14 (B. Richardson, K.B., S. Nowak and M.K.B.,
manuscript submitted). Therefore we favor the hypothesis that
the frequency of fusion events changes over time. This is likely
due to a limiting factor and/or FCM availability during the first
phase of fusion. The limiting factor could be a recognition or
adhesion protein such as Dumbfounded (Duf) or an unknown
factor. Duf levels at the cell surface are known to be tightly
controlled during fusion making it a good candidate (Menon
et al., 2005). FCM availability may be explained by the
correspondence between the time of transition between the two
phases of fusion and the time at which FCMs separate from one
124 K. Beckett, M.K. Baylies / Developmental Biology 309 (2007) 113–125another and become migratory. It is likely that during stages
12–13 FCs/myotubes can only fuse with the FCMs that they
contact (consistent with our observation that the most external
FCMs are depleted first). The subsequent, and majority of,
fusion events are prevented until the FCMs are able to migrate
externally to contact FCs/myotubes. We currently favor a
combination of these two models and testing these models is a
topic of active investigation.
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